Jitendra Wadhane - Net Worth and Insider Trading
Jitendra Wadhane Net Worth
The estimated net worth of Jitendra Wadhane is at least $975,829 dollars as of 2024-04-27. Jitendra Wadhane is the Chief Accounting Officer of Pyxis Oncology Inc and owns about 226,937 shares of Pyxis Oncology Inc (PYXS) stock worth over $975,829. Details can be seen in Jitendra Wadhane's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jitendra Wadhane has not made any transactions after 2023-09-27 and currently still holds the listed stock(s).
Transaction Summary of Jitendra Wadhane
Jitendra Wadhane Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jitendra Wadhane owns 1 companies in total, including Pyxis Oncology Inc (PYXS) .
Click here to see the complete history of Jitendra Wadhane’s form 4 insider trades.
Insider Ownership Summary of Jitendra Wadhane
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PYXS | Pyxis Oncology Inc | 2023-09-27 | Chief Accounting Officer |
Jitendra Wadhane Latest Holdings Summary
Jitendra Wadhane currently owns a total of 1 stock. Jitendra Wadhane owns 226,937 shares of Pyxis Oncology Inc (PYXS) as of September 27, 2023, with a value of $975,829.
Latest Holdings of Jitendra Wadhane
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PYXS | Pyxis Oncology Inc | 2023-09-27 | 226,937 | 4.30 | 975,829 |
Holding Weightings of Jitendra Wadhane
Jitendra Wadhane Form 4 Trading Tracker
According to the SEC Form 4 filings, Jitendra Wadhane has made a total of 3 transactions in Pyxis Oncology Inc (PYXS) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Pyxis Oncology Inc is the acquisition of 2,500 shares on September 27, 2023, which cost Jitendra Wadhane around $4,675.
Insider Trading History of Jitendra Wadhane
- 1
Jitendra Wadhane Trading Performance
GuruFocus tracks the stock performance after each of Jitendra Wadhane's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jitendra Wadhane is -1.82%. GuruFocus also compares Jitendra Wadhane's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jitendra Wadhane within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jitendra Wadhane's insider trading performs compared to the benchmark.
Performance of Jitendra Wadhane
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.99 | -1.82 | 127.57 | |||
| Relative Return to S&P 500(%) | -4.87 | -12.33 | 106.15 |
Jitendra Wadhane Ownership Network
Ownership Network List of Jitendra Wadhane
Ownership Network Relation of Jitendra Wadhane
Jitendra Wadhane Owned Company Details
What does Pyxis Oncology Inc do?
Who are the key executives at Pyxis Oncology Inc?
Jitendra Wadhane is the Chief Accounting Officer of Pyxis Oncology Inc. Other key executives at Pyxis Oncology Inc include Chief Financial Officer Pamela Ann Connealy , director & Chief Executive Officer Lara Sullivan , and 10 percent owner Pfizer Inc .
Pyxis Oncology Inc (PYXS) Insider Trades Summary
Over the past 18 months, Jitendra Wadhane made 3 insider transaction in Pyxis Oncology Inc (PYXS) with a net purchase of 10,000. Other recent insider transactions involving Pyxis Oncology Inc (PYXS) include a net purchase of 31,426 shares made by Pamela Ann Connealy , a net purchase of 3,623,188 shares made by Pfizer Inc , and a net sale of 36,558 shares made by Lara Sullivan .
In summary, during the past 3 months, insiders sold 0 shares of Pyxis Oncology Inc (PYXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,558 shares of Pyxis Oncology Inc (PYXS) were sold and 3,664,614 shares were bought by its insiders, resulting in a net purchase of 3,628,056 shares.
Pyxis Oncology Inc (PYXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pyxis Oncology Inc Insider Transactions
Jitendra Wadhane Mailing Address
Above is the net worth, insider trading, and ownership report for Jitendra Wadhane. You might contact Jitendra Wadhane via mailing address: 35 Cambridge Park Drive, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
